Apogee Therapeutics, Inc. (APGE)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

2

(1)

2

0

1

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
04-Oct-24 8:01 PM View:	02-Oct-24 Sale (Planned) ($2.25M)	Henderson Michael Thomas Chief Executive Officer Director		Apogee Therapeutics, Inc. - APGE	(9%) 1.49M to 1.35M	0	0	--	--	Show Txns Hide Txns

23-Aug-24 8:05 PM View:	23-Aug-24 Sale ($289.56K)	Henderson Jane Chief Financial Officer		Apogee Therapeutics, Inc. - APGE	(3%) 206.87K to 200.87K	0	0	--	--	Show Txns Hide Txns

04-Oct-24 8:02 PM View:	02-Oct-24 Sale (Planned) ($374.95K)	Dambkowski Carl Chief Medical Officer		Apogee Therapeutics, Inc. - APGE	(9%) 300.79K to 274.13K	0	0	--	--	Show Txns Hide Txns

01-Apr-24 5:44 PM View:	28-Mar-24 Disposition (other) 0	Fairmount Funds Management ... Director		Apogee Therapeutics, Inc. - APGE	141% 892.53K to 2.15M	0	0	--	--	Show Txns Hide Txns